期刊文献+

富含CpG的脱氧核苷酸片段对破骨细胞形成的调节作用 被引量:2

CpG oligonucleotides in mediating osteoclast differentiation
下载PDF
导出
摘要 目的 :研究富含CpG的脱氧核苷酸片段 (ODN)调节破骨细胞 (OC)的形成 .方法 :分离小白鼠骨髓单核细胞 ,单纯骨髓单核细胞或骨髓单核细胞分别与 30 μg/L CSF ;30 μg/L CSF ,2 0 μg/LRANKL ;30 μg/LM CSF以及不同浓度ODN共同培养 1~ 4d .结果 :ODN可以诱导骨髓单核细胞分化为TRAP阳性的破骨细胞 ,这些细胞表达降钙素受体 .Northernblot显示 :随着ODN浓度由 5nmol/L增加至 1 0 0nmol/L ,细胞TNF αmRNA表达量也随之增加 ;骨髓单核细胞与 30 μg/LM CSF ,2 0nmol/LODN 1 82 6共同培养 1 ,2 ,3和 4d ,同样显示随着时间延长 ,细胞TNF α表达也逐渐增加 .结论 :ODN可以刺激破骨细胞的转化 ,为临床骨疾病的治疗开辟了一个新途径 . AIM: CpG oligonucleotides were studied in their mediation of osteoclast differentiation. METHODS: Mouse bone marrow mononuclear cells were separated and simple bone marrow mononuclear cells or bone marrow mononuclear cells were incubated separately with 30 μg/L M CSF, 30 μg/L M CSF and 20 μg/L RANKL or with 30 μg/L M CSF and CpG ODN of different concentrations for 1-4 d. RESULTS: CpG ODN induced bone marrow mononuclear cells to differentiate into TRAP positive osteoclasts and these cells expressed calcitonin receptors. Northern blot showed that the expression of TNF α mRNA increased with the increase of ODN from 5 nmol/L to 100 mol/L and it also increased gradually with prolonging time. CONCLUSION: CpG ODN stimulates the transformation of osteoclast, thus CpG ODN providing a potential therapeutic approach in treating bone diseases.
出处 《第四军医大学学报》 CAS 北大核心 2004年第15期1386-1388,共3页 Journal of the Fourth Military Medical University
  • 相关文献

参考文献13

  • 1曾晓峰.破骨细胞的分化及可溶性因子调节[J].医学研究生学报,2003,16(3):215-218. 被引量:3
  • 2Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J]. Cell, 1998; 93: 165-176.
  • 3Quinn JM, Elliott J, Gillespie MT, et al. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro [J]. Endocrinology, 1998; 139: 4424-4427.
  • 4Yi AK, Peckham DW, Ashman RF, et al. CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway [J]. Int Immunol, 1999; 11: 2015-2024.
  • 5Decker T, Schneller F, Sparwasser T, et al. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and immunogenic phenotype in chronic lymphocytic leukemia B cells [J]. Blood, 2000; 95:999-1006.
  • 6Sparwasser T, Koch ES, Vabulas RM, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells [J]. Eur J Immunol, 1998; 28:2045-2054.
  • 7Zou W, Hakim I, Tschoep K, et al. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism [J]. J Cell Biochem, 2001; 83(1): 70-83.
  • 8Azuma Y, Kaji K, Katogi R, et al. Tumor necrosis factors-alpha induces differentiation of and bone resorption by osteoclasts [J]. J Biol Chem, 2000; 275(7) : 4858-4864.
  • 9Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factors alpha stimulates osteoclast differentiation by a mechanism in-dependent of the ODF/ RANKL2RANK interaction [J]. J Exp Med, 2000; 191(2): 275-286.
  • 10Inoue M, Ross FP, Erdmann JM, et al. Tumor necrosis factors alpha regulate alpha (v) beta5 integrin expression by osteoclastprecursors in vitro and in vivo [J]. Endocrinology, 2000; 141(1):284-290.

二级参考文献20

  • 1Atkins GJ, Haynes DR, Geary SM, et al. Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation[J]. Bone, 2000, 26(6): 653-661.
  • 2Teti A,Marchisio PC . Clear zone in osteoclast function. Role of podosomes in regulation of bone-resorbing activity[J]. Am Physiol,1991, 261: C1.
  • 3Athanason NA. Cellular biology of bone-resorbing cell[J]. J Bone Joint Surg Am, 1996, 78(7): 1096-1103.
  • 4Kurihara N, Chenu C. Identification of committed mononuclear precursors for osteoclast-like cell formed in long term himen marrow cultures[J]. Endocrinology, 1990, 126: 2733-2740.
  • 5Menaa C, Kurihara N, Roodman GD. CFU-GM-derived cells form osteoclasts at a very high efficiency[J]. Biochem Biophys Res Commun, 2000, 267(3): 943-946.
  • 6Sundquist KT, Cecchini MG, Marks SC Jr. Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic(op) mice[J]. Bone, 1995, 16: 39.
  • 7Fujikawa Y. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumetord arthritis[J]. Ann Rheum Dis,1996, 55(1): 816-827.
  • 8Sabokbar A, Crawford R, Murray DW, et al. Macrophage-osteoclast differentiation and bone resorption in osteoarthrotic subchondral acetabular cysts[J]. Acta Orthop Scand, 2000, 71(3): 255-261.
  • 9UyHL, Dallas M, Calland JW, et al. Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage[J]. J Bone Miner Res, 1995, 10: 295-305.
  • 10Fox SW, Fuller K, Chambers TJ. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro[J]. J Cell Physiol ,2000, 184(3): 334-340.

共引文献2

同被引文献18

  • 1Han GH, Chen YP, Hou JH, et al. Effects of simvastatin on relapse and remodeling of periodontal tissues after tooth movement in rats[J]. Am J Orthod Dentofaeial Orthop,2010, 138 (5): 550. e1-7.
  • 2Zou W, Amcheslavsky A, Bar Shavit Z. CpO oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via toll-like receptor 9 [J]. J Biol Chem, 2003,278 (19): 16732-16740.
  • 3Ameheslavsky A, Hemmi H, Akira S, et al. Differential contribution of osteoclast and osteoblast lineage cells to CpG- oligodeo-xynucleotide ( CpG-ODN ) modulation of osteoclastogenesis [J]. J Bone Miner Res, 2005, 20 (9): 1692-1699.
  • 4Chang JH, Chang EJ, Kim HH, et al. Enhanced inhibitory effects of a novel CpG motif on osteoclast differentiation via TREM-2 down-regulation [ J ]. Bioehem Biophys Res Commun, 2009, 389 (1) : 28-33.
  • 5Kigasawa K, Kajimoto K, Nakamura T, et al . Noninvasive and efficient transdermal delivery of CpO oligodeo- xynucleotide for cancer immunotherapy [J]. J Control Release, 2011, 150 (3): 256-265.
  • 6Fukuyama Y, King JD, Kataoka K, et al. A combination of fit3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory IgA immunity to streptococcus pneumoniae in aged mice [J]. J Immunol, 2011, 186 (4): 2454-2461.
  • 7NemotoE, Honda T, Kanaya S, et al. Expression of functional toll-like receptors and nueleotide-binding oligomerization domain proteins in murine cementoblasts and their upregulation during cell differentiation [J]. J Periodont Res, 2008, 43 (5): 585-593.
  • 8Tokunaga T, Yano O, Kuramoto E, et al. Synthetic oligonueleotides with particular base sequences from the eDNA encoding proteins of mycobacerium bovis BCG induce intefereon and activate natural killer cells [J].Microbiol Immunol, 1992, 36 (1): 55 66.
  • 9申玉芹.寡核苷酸(ODN)促骨髓间充质干细胞向成骨细胞分化作用及机制研究[D].长春:吉林大学,2010.
  • 10Thomas MJ, Robert L. Orthodontics-current principle and techniques [J]. Orthod Waves, 1999, 58:416-427.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部